Harold Visit 1: A 56-year old African American man with type 1 diabetes and leg pain (Version 1)
| Title: | Harold Visit 1: A 56-year old African American man with type 1 diabetes and leg pain (Version 1) |
| Topic: | Diabetology |
| Relevant Terms: | Cardiometabolic Risk, Endocrinology, Erectile Dysfunction, Hypertension, Kidney Disease, Peripheral Arterial Disease, Peripheral Diabetic Neuropathy |
| Primary Audience: | Primary Care Physicians; Nurse Practitioners and other health care professionals treating diabetic patients |
| Launch Date: | 09-Nov-11 |
| Credits: | 0.75 AMA PRA Category 1 Credit™ |
| Expiration Date: | The accreditation for this activity has expired. |
| Curriculum Name: | Managing Cardiometabolic Risk in the Context of Diabetes |
Learning Objectives
After completing this activity, the participant will demonstrate the ability to:
- Identify people who have not achieved recommended treatment targets for diabetes and related complication prevention
- Demonstrate the ability to identify factors that put people with diabetes at increased cardiometabolic risk based on nonglycemic issues, including hypertension, dyslipidemia, and obesity
- Demonstrate the ability to select interventions that blunt development of classic diabetes complications
- Describe what services their practices currently can provide, and which need to be either developed or referred to area resources to optimize their ability to provide comprehensive diabetes care
Faculty
Alan Leifeste, MD
Family Practice Specialist
Staff Physician
Southeast Texas Medical Associates
Beaumont, TX
Lyle D. Mitzner, MD
Instructor in Medicine
Harvard Medical School
Attending Physician in Endocrinology
Beth Israel Deaconess Medical Center
Staff Physician
Joslin Diabetes Center
Boston, MA
William P. Conners, MD
Clinical Instructor of Urology
Harvard Medical School
Joslin Diabetes Center
Beth Israel Deaconess Medical Center
Boston, MA
Robert C. Stanton, MD
Associate Professor of Medicine
Harvard Medical School
Chief of Nephrology
Joslin Diabetes Center
Boston, MA
Family Practice Specialist
Staff Physician
Southeast Texas Medical Associates
Beaumont, TX
Lyle D. Mitzner, MDInstructor in Medicine
Harvard Medical School
Attending Physician in Endocrinology
Beth Israel Deaconess Medical Center
Staff Physician
Joslin Diabetes Center
Boston, MA
William P. Conners, MDClinical Instructor of Urology
Harvard Medical School
Joslin Diabetes Center
Beth Israel Deaconess Medical Center
Boston, MA
Robert C. Stanton, MDAssociate Professor of Medicine
Harvard Medical School
Chief of Nephrology
Joslin Diabetes Center
Boston, MA
Planning Committee
Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center
Boston, MA
Julie Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA
Karen Kuc
Assistant Director
Professional Education
Joslin Diabetes Center
Boston, MA
James Neighbours, Med
Associate Director
Education Design
Education Design
Professional Education
Joslin Diabetes Center
Boston, MA
Eyiuche Okeke, MD
Instructor in Medicine
Harvard Medical School
Outcomes Investigator
Department of Professional Education
Staff Endocrinologist
Joslin Diabetes Center
Boston, MA
Instructor in Medicine
Harvard Medical School
Outcomes Investigator
Department of Professional Education
Staff Endocrinologist
Joslin Diabetes Center
Boston, MA
Jonathan Scoble
Grants Manager
Professional Education
Joslin Diabetes Center
Boston, MA
Kenneth J. Snow, MD, MBA
Assistant Professor of Clinical Medicine
Harvard Medical School
Director, Medical Programs, Strategic Initiatives
Senior Physician, Adult Diabetes Section
Joslin Diabetes Center
Boston, MA
Assistant Professor of Clinical Medicine
Harvard Medical School
Director, Medical Programs, Strategic Initiatives
Senior Physician, Adult Diabetes Section
Joslin Diabetes Center
Boston, MA
CME Advisory Committee
Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center
Boston, MA
Julie Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA
Enrique Caballero, MD
Director, Medical Affairs
Professional Education
Director, Latino Diabetes Initiative
Joslin Diabetes Center
Boston, MA
Director, Medical Affairs
Professional Education
Director, Latino Diabetes Initiative
Joslin Diabetes Center
Boston, MA
Jerry Cavallerano, OD, PhD
Optometrist
Beetham Eye Institute
Joslin Diabetes Center
Boston, MA
A. Patrick Egan, MD
Family Practice
Internal Medicine Specialist
Internal Medicine Specialist
Dorchester House Multi-Service Center
Boston, MA
Ann E. Goebel-Fabbri, PhD
Instructor in Psychiatry
Harvard Medical School
Psychologist
Behavioral and Mental Health Unit
Joslin Diabetes Center
Boston, MA
Osama Hamdy, MD, PhD, FACE
Assistant Professor of Medicine
Harvard Medical School
Medical Director, Obesity Clinical Program
Joslin Diabetes Center
Boston, MA
Karen Kuc
Assistant Director
Professional Education
Joslin Diabetes Center
Boston, MA
James Neighbours, Med
Associate Director
Education Design
Education Design
Professional Education
Joslin Diabetes Center
Boston, MA
Jonathan Scoble
Grants Manager
Professional Education
Joslin Diabetes Center
Boston, MA
Kenneth J. Snow, MD, MBA
Assistant Professor of Clinical Medicine
Harvard Medical School
Director, Medical Programs, Strategic Initiatives
Senior Physician, Adult Diabetes Section
Joslin Diabetes Center
Boston, MA
Assistant Professor of Clinical Medicine
Harvard Medical School
Director, Medical Programs, Strategic Initiatives
Senior Physician, Adult Diabetes Section
Joslin Diabetes Center
Boston, MA
Robert C. Stanton, MD
Associate Professor of Medicine
Harvard Medical SchoolF
Chief of Nephrology
Joslin Diabetes Center
Boston, MA
Howard Wolpert, MD
Assistant Professor of Medicine
Harvard Medical School
Director, Insulin Pump Program
Senior Physician
Joslin Diabetes Center
Boston, MA
DISCLOSURE POLICY STATEMENT
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of the Joslin Diabetes Center.
Faculty
Dr. Imtiaz Anwar has no relevant financial relationships.
Dr. William P. Conners is a consultant for Slate Pharmaceuticals, and has received grants and research support from GlaxoSmithKline, Endo Pharmaceuticals, and Auxilium Pharmaceuticals, Inc.
Dr. Jason L. Gaglia has no relevant financial relationships.
Dr. Om Ganda is on the speakers bureau for Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Briston-Myers Squibb Company, Merck & Co., Inc., and Novo Nordisk Inc.; and is a consultant and on the speakers bureau for Daiichi Sankyo, Inc.
Dr. Alan Leifeste has no relevant financial relationships.
Dr. Lyle Mitzner has no relevant financial relationships.
Dr. Robert Stanton has served as a speaker for Concert Pharmaceuticals.
Planning Committee
Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is a consultant for CeQur LTD.**
Julie A. Brown, Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.**
Dr. Okeke, outcomes investigator, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
Dr. Kenneth J. Snow, Senior Physician, Adult Diabetes Section, Joslin Diabetes Center, has no relevant financial relationships.**
**Also on the CME Advisory Commitee
CME Advisory Committee
Dr. Enrique Caballero, Director, Medical Affairs, Professional Education, Director, Latino Diabetes Initiative, Joslin Diabetes Center, is a consultant and on the speakers bureau and scientific advisory board for Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., and Eli Lilly and Company.
Dr. Jerry Cavallerano, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.
Dr. A. Patrick Egan, Family Practice, Internal Medicine Specialist, Dorchester House Multi-Service Center, has no relevant financial relationships.
Anne E. Goebel-Fabbri, Psychologist, Behavioral and Mental Health Unit, Joslin Diabetes Center, has no relevant financial relationships.
Dr. Osama Hamdy, Medical Director, Obesity Clinical Program, Joslin Diabetes Center, is on the speakers bureau for Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Novo Nordisk Inc., sanofi-aventis U.S., and Takeda Pharmaceuticals North America, Inc.
Karen J. Kuc, Assistant Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
James Neighbours, Associate Director, Education Design, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.*
Jonathan Scoble, Grants Manager, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.*
Dr. Robert C. Stanton, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships.
Dr. Howard A. Wolpert, Director of the Insulin Pump Program and Senior Physician, Joslin Diabetes Center, is a consultant for Abbott Diabetes Care, Insulet Corporation, Novo Nordisk, Inc., and Becton, Dickinson and Company.
*Also on the planning committee.
ACCREDITATION STATEMENT
The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION
Joslin Diabetes Center designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To Obtain CME Credits
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the post-test and activity evaluation.
- Physicians who successfully complete the post-test and evaluation will receive CME credit.
- You must score 60% or higher on the post-test to receive credit for this activity.
- All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
|
PC
Internet Explorer (v6 or greater), or Firefox |
MAC
Safari |
Release Date: November 9, 2011
Expiration Date: November 8, 2012
ACKNOWLEDGEMENT
This activity is sponsored by Joslin Diabetes Center.
This activity is supported by educational grants from Daiichi Sankyo, Inc., Eli Lilly and Company, Novo Nordisk Inc., Merck & Co., Inc., and Takeda Pharmaceuticals North America, Inc.
If you have any questions regarding this activity, send an email to profedweb@joslin.harvard.edu.
Copyright © 2011 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.
